IMMUNOTHERAPEUTIC AGENT CONTAINING DIRNA AS ACTIVE INGREDIENT

摘要

It is intended to provide a substance exerting an immunostimulatory action useful for immunotherapy for cancer, particularly a substance which induces the production of IFN-ß and/or enhances NK activity in cells associated with human immunity. The invention provides an immunotherapeutic agent containing as an active ingredient, diRNA including RNA derived from measles virus, and an immunotherapeutic composition for tumors containing the immunotherapeutic agent and a Gram-positive bacterial cell wall structure. The immunotherapeutic agent of the invention can be an extremely safe drug which can enhance a human immune defense ability against foreign substances such as bacteria or neoplastic tumors such as cancer.